London, United Kingdom

Christopher G Smith

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cancer Research Technology Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher G Smith. Retrieved from https://idiyas.com/inventor/christopher-g-smith-1p8617n3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher G. Smith and His Work in Cancer-Related Invention.

Introduction

Christopher G. Smith is an inventor based in London, United Kingdom. His patent work concerns methods for detecting cell-free DNA, including circulating tumour DNA, in samples obtained from patients.

Latest Patents

The provided information lists 1 patent associated with Smith: “Variant detection.” The invention describes a computer-implemented method that uses sequence data from patient samples to assess mutations at multiple tumour-specific loci. It calculates the mutant allele fraction and uses that result to classify whether the sample contains the target cell-free DNA. The disclosure also covers related methods and systems.

Career Highlights

Smith is associated with Cancer Research Technology Limited. His listed invention applies genomic sequencing and mutation analysis to the detection of tumour-derived DNA, an approach relevant to cancer research and patient testing.

Collaborations

The provided information identifies Katrin Heider and Charles Massie as Smith’s coworkers. Their specific roles in the patent or related work are not stated.

Conclusion

Christopher G. Smith’s listed patent focuses on detecting tumour-associated cell-free DNA through analysis of patient-specific mutations, reflecting the application of computational and genomic methods to cancer research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…